Associated Banc Corp Xencor Inc Transaction History

Associated Banc Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	$30.09 - $43.02 $1,323 - $1,892	-44 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $1,221 - $1,470	44 New	44 $1,000

215

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.38B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

Stay updated on Associated Banc Corp with notifications on news.